UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.59 +0.60 (+0.76%) GOLD FUTURES
2,351.70 +29.40 (+1.27%) DOW
39,387.76 +331.37 (+0.85%) Bitcoin GBP
49,972.58 +868.01 (+1.77%)
YMAB May 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:48AM EDT. Market open.
| Previous close | 9.65 |
| Open | 9.65 |
| Bid | 8.10 |
| Ask | 11.30 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 9.65 - 9.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Insider MonkeyY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Earnings Conference Call for the First Quarter of 2024. […]
- GuruFocus.com
Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Amidst leadership changes and competitive pressures, Y-mAbs Therapeutics Inc reports robust U.S. sales growth and strategic global expansions.
- Thomson Reuters StreetEvents
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.